Variant report

Variant	rs1989839
Chromosome Location	chr3:50378946-50378947
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:29)
CpG islands
(count:0)
Chromatin interactive
region (count:9)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:29 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	POLR2A	chr3:50377316-50379018	PBDE	blood:	n/a	n/a
2	STAT5A	chr3:50378084-50378972	GM12878	blood:	n/a	chr3:50378442-50378454
3	SMARCB1	chr3:50377741-50379285	Hela-S3	cervix:	n/a	n/a
4	CHD2	chr3:50377796-50378964	GM12878	blood:	n/a	n/a
5	RELA	chr3:50377556-50378992	GM15510	blood:	n/a	n/a
6	MYC	chr3:50377817-50379117	NB4	blood:	n/a	n/a
7	POLR2A	chr3:50376934-50379464	HL-60	blood:	n/a	n/a
8	PML	chr3:50377547-50378963	GM12878	blood:	n/a	n/a
9	POLR2A	chr3:50377182-50379021	GM12892	blood:	n/a	n/a
10	SMARCC1	chr3:50377519-50379109	Hela-S3	cervix:	n/a	n/a
11	POLR2A	chr3:50376960-50378970	HL-60	blood:	n/a	n/a
12	POLR2A	chr3:50377707-50379208	GM15510	blood:	n/a	n/a
13	POLR2A	chr3:50377623-50378947	GM12892	blood:	n/a	n/a
14	RUNX3	chr3:50377825-50379075	GM12878	blood:	n/a	chr3:50378511-50378526
15	POLR2A	chr3:50377107-50378957	GM12891	blood:	n/a	n/a
16	ELK4	chr3:50378366-50378955	Hela-S3	cervix:	n/a	n/a
17	HCFC1	chr3:50377492-50379038	Hela-S3	cervix:	n/a	n/a
18	POLR2A	chr3:50377067-50379419	NB4	blood:	n/a	n/a
19	MAX	chr3:50377656-50379352	NB4	blood:	n/a	n/a
20	MTA3	chr3:50377208-50378946	GM12878	blood:	n/a	n/a
21	POLR2A	chr3:50377102-50379641	Hela-S3	cervix:	n/a	n/a
22	POLR2A	chr3:50377766-50379073	GM12878	blood:	n/a	n/a
23	POLR2A	chr3:50377473-50379029	Hela-S3	cervix:	n/a	n/a
24	ELF1	chr3:50377751-50379366	GM12878	blood:	n/a	n/a
25	POLR2A	chr3:50377792-50379035	GM12892	blood:	n/a	n/a
26	RELA	chr3:50378240-50379002	GM18951	blood:	n/a	n/a
27	POLR2A	chr3:50377209-50378951	GM19099	blood:	n/a	n/a
28	POLR2A	chr3:50377590-50378977	GM12878	blood:	n/a	n/a
29	POLR2A	chr3:50377629-50378964	GM12878	blood:	n/a	n/a

No data

(count:9 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr3:50376891..50380040-chr3:50387225..50390511,3	MCF-7	breast:
2	chr3:50339705..50341283-chr3:50377540..50380265,2	K562	blood:
3	chr3:50336373..50338366-chr3:50377598..50379105,2	K562	blood:
4	chr12:21653898..21654700-chr3:50378179..50378989,2	Hela-S3	cervix:
5	chr3:50373715..50376793-chr3:50377375..50380061,4	MCF-7	breast:
6	chr3:50264037..50266762-chr3:50376102..50379754,3	K562	blood:
7	chr3:50371739..50377775-chr3:50378206..50384768,10	MCF-7	breast:
8	chr3:50359840..50362158-chr3:50378433..50381036,4	MCF-7	breast:
9	chr3:50303166..50306016-chr3:50377616..50380162,2	MCF-7	breast:

No data

Variant related genes	Relation type
RASSF1	TF binding region
ENSG00000114388	Chromatin interaction
ENSG00000012171	Chromatin interaction
ENSG00000114353	Chromatin interaction
ENSG00000068001	Chromatin interaction
ENSG00000068028	Chromatin interaction
ENSG00000272104	Chromatin interaction
ENSG00000114378	Chromatin interaction
ENSG00000114395	Chromatin interaction
ENSG00000004700	Chromatin interaction
ENSG00000232352	Chromatin interaction
ENSG00000243477	Chromatin interaction
ENSG00000186792	Chromatin interaction

Extended variants
information (count: 80 )
Associated
traits (count: 3 )

rSNPs within LD-proxies of this variant (count:59)

rs_ID	r²[population]
rs10510755	1.00[CEU][hapmap];0.90[GIH][hapmap];0.87[TSI][hapmap]
rs11130248	0.84[CHD][hapmap]
rs12054403	0.81[CHB][hapmap];0.84[CHD][hapmap]
rs12485390	0.83[JPT][hapmap]
rs12485909	0.81[CHD][hapmap]
rs12488302	0.81[CHB][hapmap];0.84[CHD][hapmap]
rs12492880	0.84[CHD][hapmap]
rs12494414	0.88[CHD][hapmap];0.87[JPT][hapmap]
rs12629572	1.00[CEU][hapmap];0.89[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.86[LWK][hapmap];1.00[MEX][hapmap];0.94[TSI][hapmap];0.94[AMR][1000 genomes];0.92[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs12635953	0.82[EUR][1000 genomes]
rs2071203	0.84[CHD][hapmap]
rs2071204	0.84[CHD][hapmap]
rs2071802	1.00[CEU][hapmap];0.81[EUR][1000 genomes]
rs2071803	1.00[CEU][hapmap];0.91[GIH][hapmap];0.88[TSI][hapmap];0.81[EUR][1000 genomes]
rs2073498	0.93[CEU][hapmap];0.86[GIH][hapmap];0.94[TSI][hapmap];0.84[EUR][1000 genomes]
rs2073499	0.93[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[JPT][hapmap];0.87[MEX][hapmap];1.00[ASN][1000 genomes]
rs2073500	0.84[CHD][hapmap]
rs2233474	0.93[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[JPT][hapmap];0.87[MEX][hapmap];0.98[ASN][1000 genomes]
rs2233476	0.84[CHD][hapmap]
rs2236939	0.86[CEU][hapmap];0.95[GIH][hapmap];0.94[TSI][hapmap]
rs2236944	0.84[CHD][hapmap]
rs2236946	0.84[CHD][hapmap];0.82[JPT][hapmap]
rs2236948	0.94[ASN][1000 genomes]
rs2236950	0.84[CHB][hapmap];0.88[CHD][hapmap];0.81[GIH][hapmap];0.86[JPT][hapmap];0.82[MEX][hapmap];0.85[ASN][1000 genomes]
rs2236951	0.89[CHB][hapmap];0.93[CHD][hapmap];0.95[JPT][hapmap];0.88[ASN][1000 genomes]
rs2239801	1.00[CEU][hapmap];0.82[EUR][1000 genomes]
rs2282751	1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[JPT][hapmap];0.87[MEX][hapmap];0.83[ASN][1000 genomes]
rs2285043	0.84[CHD][hapmap]
rs2298953	0.81[CHD][hapmap]
rs2298954	0.81[CHD][hapmap]
rs2301639	1.00[CEU][hapmap];0.91[GIH][hapmap];0.94[TSI][hapmap];0.88[EUR][1000 genomes]
rs2526392	0.86[GIH][hapmap]
rs2526394	0.86[GIH][hapmap]
rs2526395	0.86[GIH][hapmap]
rs2526396	0.85[GIH][hapmap]
rs2624837	0.86[GIH][hapmap]
rs2624842	0.86[GIH][hapmap]
rs28365992	1.00[CEU][hapmap];0.95[GIH][hapmap];0.94[TSI][hapmap];0.81[EUR][1000 genomes]
rs3213621	0.80[ASW][hapmap];0.84[CHD][hapmap];0.88[LWK][hapmap];0.95[YRI][hapmap];0.94[AFR][1000 genomes]
rs35455589	0.82[CHD][hapmap]
rs35587949	0.84[CHD][hapmap]
rs3774753	0.81[CHD][hapmap]
rs3774755	0.82[CHD][hapmap]
rs3806708	1.00[CEU][hapmap];0.95[GIH][hapmap]
rs4141060	0.93[CEU][hapmap];1.00[CHB][hapmap];0.97[CHD][hapmap];1.00[JPT][hapmap];0.87[MEX][hapmap];0.83[ASN][1000 genomes]
rs45536634	0.88[EUR][1000 genomes]
rs4688682	0.81[CHD][hapmap];0.83[JPT][hapmap]
rs4688725	0.86[AFR][1000 genomes]
rs4688732	0.84[CHD][hapmap]
rs4688734	0.84[CHD][hapmap]
rs4688741	0.81[CHD][hapmap]
rs57838764	0.89[AFR][1000 genomes];0.96[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs6776145	1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];1.00[MEX][hapmap];0.88[TSI][hapmap];0.91[AMR][1000 genomes];0.89[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs762705	0.89[ASN][1000 genomes]
rs7642692	0.88[TSI][hapmap]
rs7645537	0.81[CHD][hapmap]
rs9311449	0.93[AFR][1000 genomes]
rs9852677	0.85[CHB][hapmap];0.88[CHD][hapmap];0.83[JPT][hapmap]
rs9883222	0.81[CHD][hapmap];0.83[JPT][hapmap]

Variant overlapped rSNPs/rCNVs (count:21 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv523662	chr3:50144951-50584999	Flanking Bivalent TSS/Enh Weak transcription Genic enhancers Bivalent Enhancer Strong transcription Transcr. at gene 5' and 3' Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	101 gene(s)	inside rSNPs	diseases
2	nsv876769	chr3:50155468-50408398	Active TSS Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent/Poised TSS Strong transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	94 gene(s)	inside rSNPs	diseases
3	esv1821728	chr3:50156142-50657253	Strong transcription Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	109 gene(s)	inside rSNPs	diseases
4	esv1793751	chr3:50157364-50476363	Weak transcription Enhancers Transcr. at gene 5' and 3' Strong transcription Flanking Bivalent TSS/Enh Genic enhancers Flanking Active TSS Active TSS Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	98 gene(s)	inside rSNPs	diseases
5	esv1828162	chr3:50157364-50506151	Enhancers Genic enhancers Transcr. at gene 5' and 3' Flanking Active TSS Active TSS Weak transcription Strong transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	98 gene(s)	inside rSNPs	diseases
6	nsv470561	chr3:50158774-50584999	Flanking Active TSS Enhancers Weak transcription Genic enhancers Active TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	99 gene(s)	inside rSNPs	diseases
7	nsv876770	chr3:50158774-50609624	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	103 gene(s)	inside rSNPs	diseases
8	nsv1001993	chr3:50187646-50640808	Weak transcription Enhancers Flanking Active TSS Active TSS Genic enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	104 gene(s)	inside rSNPs	diseases
9	nsv834692	chr3:50198485-50393464	Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Genic enhancers Bivalent Enhancer Active TSS Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	94 gene(s)	inside rSNPs	diseases
10	nsv590254	chr3:50243510-50388607	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Active TSS Genic enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	93 gene(s)	inside rSNPs	diseases
11	nsv460531	chr3:50247824-50436827	Strong transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Weak transcription Active TSS Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	93 gene(s)	inside rSNPs	diseases
12	nsv590255	chr3:50247824-50436827	Weak transcription Flanking Active TSS Strong transcription Enhancers Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	93 gene(s)	inside rSNPs	diseases
13	nsv876772	chr3:50255305-50436827	Weak transcription Flanking Active TSS Strong transcription Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	93 gene(s)	inside rSNPs	diseases
14	nsv590257	chr3:50302830-50393640	Genic enhancers Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	82 gene(s)	inside rSNPs	diseases
15	nsv590256	chr3:50302830-50420554	Weak transcription Enhancers Active TSS Strong transcription Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	83 gene(s)	inside rSNPs	diseases
16	nsv876774	chr3:50302830-50436827	Enhancers Strong transcription Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	83 gene(s)	inside rSNPs	diseases
17	nsv876773	chr3:50302830-50480131	Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers Enhancers Weak transcription Strong transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	87 gene(s)	inside rSNPs	diseases
18	nsv834693	chr3:50302830-50507964	Enhancers Weak transcription Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Strong transcription Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	87 gene(s)	inside rSNPs	diseases
19	nsv876775	chr3:50324672-50504896	Flanking Active TSS Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh Genic enhancers Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	82 gene(s)	inside rSNPs	diseases
20	nsv590258	chr3:50368278-50381022	Weak transcription Bivalent/Poised TSS Flanking Active TSS Enhancers Strong transcription Genic enhancers Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA	33 gene(s)	inside rSNPs	diseases
21	esv3584502	chr3:50368278-50659741	Strong transcription Bivalent/Poised TSS Enhancers Weak transcription Flanking Active TSS Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	55 gene(s)	inside rSNPs	diseases

mRNA abundance (count:3)

SNP	Gene	Cis/trans	Tissue	Source
rs1989839	TRAIP	cis	parietal	SCAN
rs1989839	SLC25A20	cis	cerebellum	SCAN
rs1989839	NEK4	cis	parietal	SCAN

Chromatin state (count:106 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:50373800-50379200	Flanking Active TSS	Primary hematopoietic stem cells	blood
2	chr3:50374200-50379000	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
3	chr3:50375000-50379600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
4	chr3:50375200-50379000	Flanking Active TSS	Primary T cells fromperipheralblood	blood
5	chr3:50375200-50379000	Flanking Active TSS	Primary T regulatory cells fromperipheralblood	blood
6	chr3:50375200-50379200	Flanking Active TSS	Primary B cells from cord blood	blood
7	chr3:50375200-50379200	Flanking Active TSS	Primary T helper cells fromperipheralblood	blood
8	chr3:50375400-50379400	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
9	chr3:50376000-50380200	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
10	chr3:50377000-50379000	Flanking Active TSS	Primary T cells from cord blood	blood
11	chr3:50377000-50379000	Flanking Active TSS	Primary T killer naive cells fromperipheralblood	blood
12	chr3:50377000-50379000	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
13	chr3:50377000-50379000	Flanking Active TSS	Primary mononuclear cells fromperipheralblood	Blood
14	chr3:50377000-50379200	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
15	chr3:50377000-50379200	Flanking Active TSS	Foreskin Melanocyte Primary Cells skin03	Skin
16	chr3:50377000-50379200	Flanking Active TSS	Adipose Nuclei	Adipose
17	chr3:50377000-50379200	Flanking Active TSS	Colonic Mucosa	Colon
18	chr3:50377000-50380200	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
19	chr3:50377200-50379000	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
20	chr3:50377200-50379000	Flanking Active TSS	Primary T helper cells PMA-I stimulated	--
21	chr3:50377200-50379000	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
22	chr3:50377200-50379000	Active TSS	Brain Hippocampus Middle	brain
23	chr3:50377400-50379400	Flanking Active TSS	Stomach Smooth Muscle	stomach
24	chr3:50377600-50379000	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
25	chr3:50377600-50379000	Bivalent/Poised TSS	iPS DF 6.9 Cell Line	embryonic stem cell
26	chr3:50377600-50379000	Bivalent/Poised TSS	Fetal Kidney	kidney
27	chr3:50377600-50379000	Active TSS	Left Ventricle	heart
28	chr3:50377600-50379200	Flanking Active TSS	Rectal Mucosa Donor 31	rectum
29	chr3:50377800-50379000	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
30	chr3:50377800-50379200	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
31	chr3:50377800-50379200	Active TSS	HSMM	muscle
32	chr3:50377800-50379400	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
33	chr3:50378000-50379000	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
34	chr3:50378200-50379000	Bivalent Enhancer	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
35	chr3:50378200-50379200	Flanking Bivalent TSS/Enh	Fetal Muscle Leg	muscle
36	chr3:50378400-50379000	Flanking Active TSS	Primary B cells from peripheral blood	blood
37	chr3:50378400-50379000	Flanking Bivalent TSS/Enh	Fetal Intestine Small	intestine
38	chr3:50378400-50379000	Flanking Active TSS	Osteobl	bone
39	chr3:50378400-50379200	Flanking Active TSS	Primary Natural Killer cells fromperipheralblood	blood
40	chr3:50378400-50379200	Flanking Active TSS	Primary T killer memory cells from peripheral blood	blood
41	chr3:50378400-50379200	Flanking Active TSS	Duodenum Mucosa	Duodenum
42	chr3:50378400-50379200	Flanking Bivalent TSS/Enh	Fetal Muscle Trunk	muscle
43	chr3:50378400-50379200	Flanking Active TSS	Rectal Mucosa Donor 29	rectum
44	chr3:50378400-50379200	Enhancers	Sigmoid Colon	Sigmoid Colon
45	chr3:50378600-50379000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
46	chr3:50378600-50379000	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
47	chr3:50378600-50379000	Flanking Active TSS	Primary T helper memory cells from peripheral blood 1	blood
48	chr3:50378600-50379000	Flanking Active TSS	Esophagus	oesophagus
49	chr3:50378600-50379000	Flanking Active TSS	Gastric	stomach
50	chr3:50378600-50379000	Flanking Active TSS	Rectal Smooth Muscle	rectum

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links